Import-Export Bulletin Board Genrui Biotech Inc. Logo

Home > Offers to Sell > Health & Beauty > Personal Care Products > Hair Hygiene

Contact: genrui
Company: Genrui Biotech Inc.
Address:4-10F, Building 3, Geya Technology Park, Guangming District, 518106, Shenzhen, China
Shenzhen 518015
China
Phone: 86 0755-26835560
Fax: 86 0755-26678789
E-Mail: Send Inquiry
Date/Time:  8/2/22 6:13 GMT
 

COVID-19 Solutions


COVID-19 Detection and SARS-CoV-2 Detection

As we know the COVID-19 pandemic is a scientific, medical, and social
challenge. The syndrome coronavirus 2 (SARS-CoV-2) can rapidly develop, causing
severe and deadly complications. The sars cov2 test is an important method of
dealing with the pandemic. The identification of effective laboratory
biomarkers able to classify patients based on their risk is imperative in being
able to guarantee prompt treatment. Analysis of recently published studies
suggests that systemic vasculitis and cytokinin-mediated coagulation disorders
are major factors in multiple organ failure in patients with severe covid-19
testing complications.

The following biomarkers have been identified: hematological (lymphocyte count,
neutrophil count, neutrophil-lymphocyte ratio (NLR)), inflammatory (C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT)),
immunological (interleukin (IL)-6 and biochemical (D-dimer, troponin, creatine
kinase (CK), aspartate aminotransferase (AST)), especially those related to
coagulation cascades in disseminated intravascular coagulation (DIC) and acute
respiratory distress syndrome (ARDS). Genrui offers a variety of multi
biomarkers detection options and products including the Hematology analyzer,
Specific Protein Analyzer series, the chemistry analyzer series and POCT's
Quantitative Immunoassay Analyzer.

References:

Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with
COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020 Sep;57(6):389-399.
DOI: 10.1080/10408363.2020.1770685. Epub 2020 Jun 5. PMID: 32503382; PMCID:
PMC7284147.

Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in
the diagnosis of COVID-19 - A systematic review. Life Sci. 2020 Aug
1;254:117788. DOI: 10.1016/j.lfs.2020.117788. Epub 2020 May 13. PMID: 32475810;
PMCID: PMC7219356.

COVID-19 Solutions Types
Pre-processing System SP9600
SP9600 is a brand-new automated sample transfer processing system that can
transfer 96 samples from closed tubes to a 96-well plate in 20-30 minutes.
Pre-processing System SP9600
Nucleic Acid Extraction
Our instrument uses the magnetic bead nucleic acid extraction method, with
fully automatic, integrated, high extraction rate, super high-speed
characteristics.
Fully Auto Nucleic Acid Extraction Instrument NE48
Fully Auto Nucleic Acid Extraction Instrument NE96
Nucleic Acid Extraction Reagents

Nucleic Acid Detection
The Real-Time Fluorescence Quantitative PCR Instrument has automatic
integration, simple operation,fast detection speed,high sensitivity and other
advantages. The gold standard for COVID-19 diagnosis is a dem...
Nucleic Acid Detection Instrument NX-8F
Nucleic Acid Detection Reagents

Rapid Test
Genrui has COVID-19 antigen test, COVID-19 antibody test, COVID-19 rapid test
and other covid 19 test kits, with extremely high accuracy and can display the
detection results within 20 minutes.
Colloidal Gold Rapid Test
Immunofluorescence Test

Infrared Thermometer JRT200
Infrared Thermometer's test Temperature range: 32-42.9 ℃ in COVID-19 pandemic
can greatly, Avoid personnel contact, and reduce the transmission route of
COVID-19 virus.

What is the COVID-19?
The viruses that cause COVID-19 are in the coronavirus group. Under microscopy,
these organisms can be identified through their coronary shape. The lung
diseases SARS and MERS are also caused by a virus in the group. Only a few
people are immune to the currently popular novel coronavirus; so it has caused
a considerable number of victims. Most infected people have only mild
discomfort and will subside in a few days.

The symptoms of the coronavirus infection include:

Cough

Fever

Headache ,

loss of taste or smell

Repeated shaking with chills

Sore throat

Shortness of breath

Muscle pain

Some people have a worse course. COVID-19 may then be related to severe
respiratory problems, pneumonia, high fever, and severe breathing difficulties.
Not all patients with severe COVID-19 symptoms can survive. Older people are at
higher risk of severe illness, as with previous diseases such as cataracts. For
example cardiovascular disease, cancer or diabetes. Therefore, COVID-19 testing
is becoming a common thing in people's daily lives.

D-dimer level in COVID-19 infection
According to several studies from three databases, Scopus, PubMed, and Web of
Science have shown Abnormal coagulation function has been demonstrated to be
involved in the disease progression of COVID-19, elevated D-dimer in COVID-19
patients is associated with higher mortality.

Patients with severe COVID-19 have a higher level of D-dimer than those with
non-severe disease, and D-dimer greater than 0.5 μg/ml is associated with a
severe infection in patients with COVID-19.

Expert opinion: D-dimer level is one of the measures used in patients to detect
thrombosis. Studies have reported an increase in D-dimer and fibrinogen
concentrations in the early stages of COVID-19 disease a 3 to 4-fold rise in D-
dimer levels are linked to poor prognosis. In addition, underlying diseases
such as diabetes, cancer, stroke, and pregnancy may trigger an increase in D-
dimer levels in COVID-19 patients. Measuring the level of D-dimer and
coagulation parameters from the early stage of the disease can also be useful
in controlling and managing COVID-19 disease.

Genrui offers a variety of D-dimer detection options and products including the
Specific Protein Analyzer series, the chemistry analyzer series and POCT's
Quantitative Immunoassay Analyzer.

Other Biomarker of IVD Solutions
As we know the COVID-19 pandemic is a scientific, medical, and social
challenge. The syndrome coronavirus 2 (SARS-CoV-2) can rapidly develop, causing
severe and deadly complications.

The identification of effective laboratory biomarkers able to classify patients
based on their risk is imperative in being able to guarantee prompt treatment.

Analysis of recently published studies suggests that systemic vasculitis and
cytokine-mediated coagulation disorders are major factors in multiple organ
failure in patients with severe COVID-19 complications.

The following biomarkers have been identified: hematological (lymphocyte count,
neutrophil count, neutrophil-lymphocyte ratio (NLR)), inflammatory (C-reactive
protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT)),
immunological (interleukin (IL)-6 and biochemical (D-dimer, troponin, creatine
kinase (CK), aspartate aminotransferase (AST)), especially those related to
coagulation cascades in disseminated intravascular coagulation (DIC) and acute
respiratory distress syndrome (ARDS).

Genrui offers a variety of multi biomarkers detection options and products
including the Hematology analyzer, Specific Protein Analyzer series, the
chemistry analyzer series and POCT's Quantitative Immunoassay Analyzer.

If you want to know more types of china ivd products for sale, please contact
us.
COVID-19 Solutions
Enlarge Click to Enlarge
SOURCE: Import-Export Bulletin Board (https://www.imexbb.com/)
Report Abuse

Post an Offer to Sell

© 1996-2010 IMEXBB.com. All rights reserved.

IMEXBB.com